Compare 0

Canadian pharmaceuticals hemp in Croatia

heading_title

World market of medical cannabis is estimated at $ 100 billion in profits annually.
 
Major Canadian company engaged in the production of medical cannabis and its extracts containing products, has announced the beginning of its partnership with the Croatian authorities. In the country in the near future, the company will start exporting some of their names pharmaceuticals, for distribution in pharmacies across the country. For the first time in the history of the hemp industry, products of cannabisa be legally exported to such a great distance between the two countries on two continents.
 
Of course, such an achievement was an important moment for the health of consumers as living in Croatia, and for most of the Canadian firm, which hopes that this step will be only the beginning of a successful exit of the global hemp market. Canadians are trying to build their brand, acquiring a reputation as a reliable supplier of therapeutic cannabis, the quality of whose products are trusted by doctors and consumers around the world.
 
Company of Canada will provide state of the Immunology Institute of Croatia for its preparations containing tetrahydrocannabinol (THC) and cannabidiol (CBD). The products will be produced in Canada, according to the established quality standards, after which it will be checked and tested by specialists of the Institute, before it spread on Croatian pharmacies.
 
According to the Canadian side, Croatia will be imported two varieties of capsules, liquid extract of hemp for oral consumption. One formula is 5 milligrams will contain THC and CBD same amount in one capsule, while another part will have 2.5 milligrams of THC and CBD 2 milligrams. A mixture of both cannabinoid compounds will provide consumers with a long and strong therapeutic effect, preventing epileptic seizures, muscle spasms, and pain sensation, while protecting patients from unwanted intoxication.
 
Professor Ognei Brborovich, who is chairman of the committee on medical cannabis at the Croatian government welcomes the cooperation of the authorities with a Canadian firm. "We spent 8 months studying the properties of the capsules, as well as modified the laws of the country in order to allow patients to use these drugs. After that, the company is still 8 months engaged in registration of all certificates and papers required for the importation of hemp drugs to the EU territory. As a result, Croatia will become the first country in Europe to gain access to high-quality, well-established in Canada, medical drugs based on cannabis, produced one of the recognized world leaders in the production of therapeutic cannabis. we hope that soon we will be able to supply all our need the drug citizens they need portion capsules with medicinal extract, as well as that of our colleagues from other European countries will support a similar system of distribution of medical cannabis in their countries. "
 
The drug firm is recommended in the treatment of diseases such as multiple sclerosis, Draveta syndrome, cancer, HIV / AIDS, chronic pain sensation, as well as indigestion and nausea. In comparison with other available drugs in the country, imported drug can be much cheaper and safe alternative in the treatment of these ailments.
 
As a result, Croatia and the European Union became the first export market of the company on the other side of the world, more ahead in this regard, the company's agreement with the Australian Government, to start negotiations with the Canadians for the supply of the Party of the drug into the country for a series of clinical studies their effectiveness in combating the effects of chemotherapy cancer, under the University of Sydney and the provincial governments of New South Wales.
 
In a short time, the Canadian company to proceed with the negotiations on the export of their products to more near Europe, and will continue to supply clinical trials of cannabis drugs in Canada and Australia.
 
"As calculated our financial analysts, the world's medical cannabis market can be estimated at $ 100 billion in profits each year. We are very pleased that the demand for medical cannabis around the world continues to grow, and that more and more European countries are ready to take cannabis as an effective means treatment of many serious chronic diseases. we hope that the progress of legalization and new discoveries in the field of therapeutic use of cannabis can help doctors save millions of lives around the world. that is why we are always ready to cooperate with interested in testing our drug countries of the world, whom we can always lend a helping hand, "says the official press release from the Canadian company.

Information taken from the site http://tku.org.ua